Document Detail


Pigmented contact dermatitis due to therapeutic sensitizer as complication of contact immunotherapy in alopecia areata.
MedLine Citation:
PMID:  20860739     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pigmentary complication by contact immunotherapy (CI) for alopecia areata (AA) has been reported but its pathophysiology remains unknown. To characterize pigmentary complication by CI and its pathophysiology, we examined the incidence of hyperpigmentation in 186 consecutive patients treated with CI using diphenylcyclopropenone. From clinical data of AA totalis (AAT) or universalis (AAU) patients (n = 78), we studied the correlations between this complication and age, sex, atopic background, duration and treatment responsiveness, duration of CI, final concentration of diphenylcyclopropenone and administration of anti-histamines by χ(2)-test or Mann-Whitney U-test. Additionally, the histopathology of pigmentation was studied. As a result, 11 (5.91%) of the 186 patients had hyperpigmentation in this series. All of them had AAT or AAU, suggesting that the pigmentation is apt to occur in severe AA. When the AAT or AAU patients with (n = 11) and without hyperpigmentation (n = 67) were compared, those with pigmentation showed poorer responsiveness to CI (P < 0.05) but no significant tendency for other factors. Histopathologically, skin specimens showed lichenoid or vacuolar interface dermatitis with necrotic keratinocytes and dermal melanophages, consistent with pigmented contact dermatitis (PCD). Together, pigmentary complication by CI corresponds to PCD from therapeutic sensitizer, representing clinical indicator of poor responsiveness.
Authors:
Shigeki Inui; Takeshi Nakajima; Naoyuki Toda; Satoshi Itami
Related Documents :
3434159 - Phytohemagglutinin skin testing in critically ill surgical patients.
20687499 - Trichothiodystrophy: photosensitive, ttd-p, ttd, tay syndrome.
10147479 - Ultrapulse carbon dioxide laser removal of periocular wrinkles in association with lase...
2219469 - Immunotherapy with mycobacterium vaccae as an adjunct to chemotherapy in the treatment ...
6872269 - Skin thickness in patients with acromegaly and cushing's syndrome and response to treat...
16830639 - Clinical and histologic variations among thirty patients with lucio's phenomenon and pu...
17143019 - Hematological parameters in sickle cell anemia patients with and without priapism.
12955679 - Prognostic value of cardiac markers in esrd: chronic hemodialysis and new cardiac marke...
15626959 - Clinical experience with treatment of melioidosis in children.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of dermatology     Volume:  37     ISSN:  1346-8138     ISO Abbreviation:  J. Dermatol.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-23     Completed Date:  2011-01-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7600545     Medline TA:  J Dermatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  888-93     Citation Subset:  IM    
Copyright Information:
© 2010 Japanese Dermatological Association.
Affiliation:
Department of Regenerative Dermatology, Osaka University School of Medicine, Suita, Osaka, Japan. inui@r-derma.med.osaka-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Alopecia Areata / therapy*
Child
Cyclopropanes / adverse effects*
Dermatitis, Contact / etiology*
Dermatologic Agents / adverse effects*
Female
Humans
Hyperpigmentation / chemically induced*,  pathology
Immunotherapy / adverse effects*
Male
Middle Aged
Severity of Illness Index
Statistics, Nonparametric
Treatment Outcome
Young Adult
Chemical
Reg. No./Substance:
0/Cyclopropanes; 0/Dermatologic Agents; 886-38-4/diphenylcyclopropenone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Significant damage of the skin and hair following hair bleaching.
Next Document:  Clinical course of guttate psoriasis: long-term follow-up study.